Speaker illustration

Associate Professor Aaron Sverdlov

University of Newcastle, Newcastle (Australia)

Member of:

European Society of Cardiology
Heart Failure Association

Galectin 3 predicts improvement in LV volumes after Cardiac Resynchronisation Therapy

Event: HEART FAILURE 2016

Topic: Cardiac resynchronisation therapy

Session: Devices / CRT / ICD

Thumbnail

ESC 365 is supported by

logo Novo Nordisk